MY183638A - Nucleoside phosphoramidate prodrugs - Google Patents

Nucleoside phosphoramidate prodrugs

Info

Publication number
MY183638A
MY183638A MYPI2013700238A MYPI2013700238A MY183638A MY 183638 A MY183638 A MY 183638A MY PI2013700238 A MYPI2013700238 A MY PI2013700238A MY PI2013700238 A MYPI2013700238 A MY PI2013700238A MY 183638 A MY183638 A MY 183638A
Authority
MY
Malaysia
Prior art keywords
phosphoramidate prodrugs
nucleoside phosphoramidate
formula
treatment
disclosed
Prior art date
Application number
MYPI2013700238A
Inventor
Michael Joseph Sofia
Peiyuan Wang
Dhanapalan Nagarathnam
Jinfa Du
Original Assignee
Gilead Pharmasset Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Pharmasset Llc filed Critical Gilead Pharmasset Llc
Priority to MYPI2013700238A priority Critical patent/MY183638A/en
Publication of MY183638A publication Critical patent/MY183638A/en

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Disclosed herein are phosphoramidate prodrugs of nucleoside derivatives for the treatment of viral infections in mammals, which is a compound, its stereoisomer, salt (acid or basic addition salt), hydrate, solvate, or crystalline form thereof, represented by the following structure: [formula I] Also disclosed are methods of treatment, uses, and processes for preparing each of which utilize the compound represented by formula I.
MYPI2013700238A 2008-03-26 2008-03-26 Nucleoside phosphoramidate prodrugs MY183638A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2013700238A MY183638A (en) 2008-03-26 2008-03-26 Nucleoside phosphoramidate prodrugs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2013700238A MY183638A (en) 2008-03-26 2008-03-26 Nucleoside phosphoramidate prodrugs

Publications (1)

Publication Number Publication Date
MY183638A true MY183638A (en) 2021-03-04

Family

ID=82802234

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2013700238A MY183638A (en) 2008-03-26 2008-03-26 Nucleoside phosphoramidate prodrugs

Country Status (1)

Country Link
MY (1) MY183638A (en)

Similar Documents

Publication Publication Date Title
PH12014502771A1 (en) Nucleoside phosphoramidate prodrugs
MX2010013768A (en) Nucleoside cyclicphosphates.
PH12017501429A1 (en) Derivatives of betulin
WO2012142523A3 (en) 1'-substituted pyrimidine n-nucleoside analogs for antiviral treatment
NZ593647A (en) Synthesis of purine nucleosides
PH12014501134A1 (en) 2',4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of hcv rna replication
NZ617066A (en) Nucleoside analogs
PH12015501585A1 (en) Manufacturing process for pyrimidine derivatives
MX2013003179A (en) 2' -fluoro substituted carba-nucleoside analogs for antiviral treatment.
MD20150036A2 (en) 2'-Chloro nucleoside analogs for HCV infection
UA111163C2 (en) METHODS AND COMPOUNDS FOR THE TREATMENT OF Viral Infections of PARAMYXOVIRIDAE
NZ593712A (en) Intermediates for synthesising nucleoside aryl phosphoramidates
MY164776A (en) Heterocyclic compound
MX350810B (en) 4'-azido, 3'-fluoro substituted nucleoside derivatives as inhibitors of hcv rna replication.
NZ631182A (en) Process for the preparation of 2-deoxy-2-fluoro-2-methyl-d-ribofuranosyl nucleoside compounds
CA2817362C (en) Lipoyl compounds and their use for treating ischemic injury
IN2014CN04449A (en)
MX2011006095A (en) Dihydroetorphines and their preparation.
MX2010009926A (en) New process for the preparatiion of cyclohexanecarboxylic acid dericatives.
WO2007083243A3 (en) An improved process for the preparation of risedronate sodium hemi-pentahydrate
MY183638A (en) Nucleoside phosphoramidate prodrugs
MY183716A (en) Nucleoside phosphoramidate prodrugs
WO2012150183A8 (en) Crystalline sodium salt of an hiv integrase inhibitor
TW200708507A (en) A process for the preparation of tetrazolyltetrahydrocyclopentapyrazoles
WO2008152518A3 (en) Process for the preparation of risedronic acid or risedronate sodium